DIVISION FOR DRUG DISCOVERY, DRUG DEVELOPMENT, AND REGULATORY AFFAIRS

The Division for Drug Discovery, Drug Development and Regulatory Affairs will impact pharmacologists in industry, government and academia with interests in all phases of the drug development process. The goal of the Division is to promote interaction between discovery scientists, physicians and regulators as we attempt to integrate the broad expanse of skills required to translate the identification of a novel molecular target into a clinically useful therapeutic entity. The DDDRA will serve to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics. Furthermore, the Division plans to provide special venues at annual meetings to Pharmacology graduate students and post-doctoral fellows involved in scientific activities of interest to the DDDRA membership as well as sponsor symposia and/or colloquia.